JQC - Nuveen Credit Strategies Income Fund

What this means for you

No investor has reported owning 5% or more of this fund. That is the normal state for most closed-end funds.

Nothing is required of you. If that changes, the notice appears here within a day of being filed with the regulator.

Email me if this changes

What happened, and when

1. April 7, 2025

   The fund said it may sell new shares.

   Original document →

2. March 20, 2025

   The fund offered holders the right to buy more shares, until April 29, 2025.

   Original document →

3. March 19, 2025

   The fund said it may sell new shares.

   Original document →

About this fund

• Run by Nuveen Fund Advisors, LLC. Part of the Nuveen fund family. As of July 31, 2025, from the fund's yearly report. Original document →
• Size: about $800 million of holdings, as of April 30, 2026. As of April 30, 2026, from the fund's quarterly holdings report. Original document →
• Borrowing: the fund borrows about 34% on top of its own money, as of April 30, 2026. Borrowed money makes gains and losses bigger. About 34% of that is money the fund has borrowed by selling preferred shares. As of April 30, 2026, from the fund's quarterly holdings report. Original document →
• Costs: 0.8% a year in management fees; 5.1% a year in total, including interest on borrowed money. Fiscal year ended July 31, 2025. As of July 31, 2025, from the fund's yearly report. Original document →
• Payouts: last fiscal year (ended July 31, 2025) the fund paid $0.65 a share. $0.50 of that was income; $0.15 was your own money back, not income. As of July 31, 2025, from the fund's annual report. Original document →
• Value of holdings per share at the last fiscal year end (July 31, 2025): $5.66. The shares traded at $5.53, about 2.3% below that. As of July 31, 2025, from the fund's yearly report. Original document →
  Over the last two years the gap ranged from 15.9% below to 0.3% below. As of July 31, 2025, from the fund's annual report. Original document →
• How the holdings did: up 1.2% over the last three months we have (Feb-April 2026), before the share price is taken into account. Over the last 12 months: +7.4%. As of April 30, 2026, from the fund's quarterly holdings report. Original document →
• How the holdings did over the fiscal year (ended July 31, 2025): the value of the holdings returned +7.1%. How the share price did: the shares returned +8.4% over the same year, counting payouts and the change in the market price. As of July 31, 2025, from the fund's annual report. Original document →
• First reported to the regulator in 2003.

What the fund holds

Mostly loans (73%), the rest bonds, shares and asset-backed bonds. About 86% issued in the U.S.

1. BlackRock Liquidity Funds T-Fund - 10.8%
2. Hopper Merger Sub, Hologic Inc., Term Loan B - 2.3%
3. Parexel International Corporation, Repriced Term Loan B - 2.1%
4. Broadstreet Partners Group LLC, Broadstreet Partners, Inc., Term Loan B4 - 1.8%
5. Surgery Center Holdings, Inc., Term Loan B - 1.6%
6. Global Medical Response, Inc., Term Loan B - 1.6%
7. Phoenix Guarantor Inc, Term Loan B - 1.3%
8. Zayo Group Holdings, Inc., Term Loan - 1.3%
9. Zayo Group Holdings - 1.3%
10. Fertitta Entertainment, LLC, Term Loan B - 1.3%

As of April 30, 2026, from the fund's quarterly holdings report. Original document →